111 Shares Outstanding 2018-2023 | YI

111 shares outstanding from 2018 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
111 Annual Shares Outstanding
(Millions of Shares)
2023 84
2022 83
2021 83
2020 82
2019 82
2018 50
2017 36
111 Quarterly Shares Outstanding
(Millions of Shares)
2023-09-30 85
2023-06-30 84
2023-03-31 84
2022-12-31 83
2022-09-30 83
2022-06-30 83
2022-03-31 83
2021-12-31 83
2021-09-30 83
2021-06-30 83
2021-03-31 83
2020-12-31 82
2020-09-30 82
2020-06-30 82
2020-03-31 82
2019-12-31 82
2019-09-30 82
2019-06-30 82
2019-03-31 82
2018-09-30 45
2018-06-30
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.088B $2.105B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.573B 22.01
Inspire Medical Systems (INSP) United States $7.095B 0.00
IRhythm Technologies (IRTC) United States $3.623B 0.00
Axonics (AXNX) United States $3.399B 0.00
10x Genomics (TXG) United States $3.279B 0.00
Enovis (ENOV) United States $3.080B 23.40
Azenta (AZTA) United States $2.905B 236.77
Olink Holding AB (publ) (OLK) Sweden $2.789B 0.00
Hims & Hers Health (HIMS) United States $2.644B 0.00
Privia Health (PRVA) United States $2.156B 95.63
Schrodinger (SDGR) United States $1.738B 0.00
Omnicell (OMCL) United States $1.260B 30.82
Phreesia (PHR) United States $1.237B 0.00
Definitive Healthcare (DH) United States $0.854B 0.00
Standard BioTools (LAB) United States $0.702B 0.00
Fulgent Genetics (FLGT) United States $0.620B 0.00
Talkspace (TALK) United States $0.519B 0.00
Health Catalyst (HCAT) United States $0.353B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.330B 0.00
Clover Health Investments (CLOV) United States $0.322B 0.00
Pulmonx (LUNG) United States $0.290B 0.00
MSP Recovery (LIFW) United States $0.158B 0.00
P3 Health Partners (PIII) United States $0.158B 0.00
American Well (AMWL) United States $0.154B 0.00
Butterfly Network (BFLY) United States $0.147B 0.00
Augmedix (AUGX) United States $0.139B 0.00
Outset Medical (OM) United States $0.132B 0.00
TruBridge (TBRG) United States $0.116B 4.95
SHL Telemedicine (SHLT) Israel $0.079B 0.00
Future Health ESG (FHLT) United States $0.068B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.044B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Movano (MOVE) United States $0.027B 0.00
Cue Health (HLTH) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Strata Skin Sciences (SSKN) United States $0.020B 0.00
Akili (AKLI) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.014B 0.00
Biotricity (BTCY) United States $0.013B 0.00
Centogene (CNTG) Germany $0.012B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00